ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹49 Cr | ₹59 Cr | ₹49 Cr | ₹44 Cr | ₹35 Cr |
What is the latest Total Non-Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹49 Cr |
Mar2022 | ₹59 Cr |
Mar2021 | ₹49 Cr |
Mar2020 | ₹44 Cr |
Mar2019 | ₹35 Cr |
How is Total Non-Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹49 Cr | -17.87 | |
Mar2022 | ₹59 Cr | 20.87 | |
Mar2021 | ₹49 Cr | 11.18 | |
Mar2020 | ₹44 Cr | 25.34 | |
Mar2019 | ₹35 Cr | - |
Compare Total Non-Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹4,421.7 Cr | 2.5% | 13.8% | 53.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | -0.1% | -6.3% | 53.5% | Stock Analytics | |
CIPLA | ₹114,614.0 Cr | 1% | -5% | 53.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,233.0 Cr | 3.2% | 15.3% | 23.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,900.0 Cr | 1.1% | 2.2% | 26% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 3.9% | -1.7% | 85.2% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | 2.5% |
13.8% |
53.7% |
SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses